#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17888	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2029	873.2	0	.	n	.	0	C451T	SNP	451	451	C	696	696	T	1068	T,C	762,229	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17888	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2029	873.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	988	C	930	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17888	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2029	873.2	0	HET	.	.	.	C393T,A	.	393	393	C	638	638	C	1072	C,T,A	753,242,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32806	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3592	910.6	0	.	n	.	0	T695C	SNP	695	695	T	1025	1025	C	941	C,T	874,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32806	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3592	910.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2301	2301	C	1104	C	1024	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32806	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3592	910.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2375	2375	A	1030	A	970	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32806	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3592	910.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2927	2927	C	1008	C	948	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	S84P	NONSYN	250	252	TCT	558	560	CCT	171;169;166	C;C;T	158;157;156	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	H102R	NONSYN	304	306	CAC	612	614	CGC	187;187;186	C;G;C	172;175;174	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	L130V	NONSYN	388	390	CTC	696	698	GTC	215;216;217	G;T;C	197;185;194	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	C135R	NONSYN	403	405	TGT	711	713	CGC	206;208;205	C;G;C	185;187;185	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	A137T	NONSYN	409	411	GCG	717	719	ACG	213;214;217	A;C;G	191;192;197	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	A167T	NONSYN	499	501	GCG	807	809	ACG	158;158;159	A;C;G	143;146;147	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	C194G	NONSYN	580	582	TGC	888	890	GGC	123;123;122	G;G;C	115;115;112	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	T204A	NONSYN	610	612	ACA	918	920	GCG	103;104;104	G;C;G	96;97;97	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	Y218L	NONSYN	652	654	TAT	960	962	TTG	95;92;88	T;T;G	86;83;84	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	E232G	NONSYN	694	696	GAA	1002	1004	GGG	64;64;62	G;G;G	64;64;60	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	G243V	NONSYN	727	729	GGA	1035	1037	GTA	85;84;84	G;T;A	77;76;77	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1065	1067	TCC	86;85;85	T;C;C	80;80;82	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	K259Q	NONSYN	775	777	AAA	1083	1085	CAA	117;116;119	C;A;A	107;106;108	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	0	.	p	.	0	A275V	NONSYN	823	825	GCG	1131	1133	GTG	163;164;162	G;T;G	154;143;151	.	.
folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867	1	1	539	1642	folP	852	852	93.66	folP.l15.c4.ctg.1	1613	101.3	1	SNP	p	R228S	1	.	.	682	684	AGC	990	992	AGC	62;62;61	A;G;C,A	60;62;59,1	folP.Neisseria_meningitidis_serogroup_A_Z2491_v1_01867:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6074	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3351	180.5	1	SNP	p	S91F	1	.	.	271	273	TTC	508	510	TTC	233;229;229	T;T;C	216;212;212	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6074	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3351	180.5	1	SNP	p	D95G	1	.	.	283	285	GGC	520	522	GGC	222;217;216	G,T;G;C,T	205,1;200;199,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6074	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3351	180.5	1	SNP	p	G95N	0	.	.	283	285	GGC	520	522	GGC	222;217;216	G,T;G;C,T	205,1;200;199,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2024	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1375	146.7	1	SNP	p	G45D	0	.	.	133	135	GGC	513	515	GGC	242;245;247	G;G;C	225;229;228	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	970	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	959	100.4	0	.	n	.	0	A197.	DEL	197	197	A	570	570	A	217	A	208	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6042	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3018	199.5	1	SNP	p	D86N	0	.	.	256	258	GAC	565	567	GAC	245;246;245	G,C,A;A;C	227,1,1;221;230	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6042	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3018	199.5	1	SNP	p	R87W	0	.	.	259	261	CGT	568	570	CGT	247;249;253	C,A;G;T	230,1;230;232	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6042	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3018	199.5	1	SNP	p	S87R	1	.	.	259	261	CGT	568	570	CGT	247;249;253	C,A;G;T	230,1;230;232	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6042	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3018	199.5	1	SNP	p	R87I	0	.	.	259	261	CGT	568	570	CGT	247;249;253	C,A;G;T	230,1;230;232	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6042	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3018	199.5	1	SNP	p	S88P	0	.	.	262	264	TCC	571	573	TCC	252;253;253	T;C;C	234;237;238	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5352	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2630	202.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1557	1559	GGC	284;281;277	G;G;C	266;262;258	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1256	1258	GCC	235;232;230	G;C;C	224;225;222	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1259	1261	ATG	231;229;227	A;T;G	224;221;220	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1271	1273	ACC	235;236;238	A;C;C	224;226;226	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1271	1273	ACC	235;236;238	A;C;C	224;226;226	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1772	1774	ACC	255;252;255	A;C;C	231;231;235	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1826	1828	GCG	286;282;280	G,A;C;G	264,1;265;261	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1826	1828	GCG	286;282;280	G,A;C;G	264,1;265;261	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1949	1951	GGT	207;206;206	G;G;T	193;193;191	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1958	1960	AGC	201;201;201	A;G;C	185;185;183	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2370	205.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1976	1978	CCG	177;175;175	C,G;C,G;G	139,3;134,1;140	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6602	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3063	214.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1588	1590	CCG	239;239;234	C,A;C;G	211,1;220;209	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2798	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1786	155.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	529	529	C	207	C	192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3236	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	1690	190.2	0	.	p	.	0	E204D	NONSYN	610	612	GAA	1055	1057	GAC	243;241;240	G;A;C	227;220;225	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3236	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	1690	190.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1073	1075	AGA	242;242;241	A;G,A;A	228;227,1;227	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3236	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	1690	190.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1094	1096	GGT	256;258;257	G;G;T	239;242;241	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3236	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	1690	190.2	0	.	p	.	0	G256D	NONSYN	766	768	GGT	1211	1213	GAT	271;267;264	G;A;T	248;246;244	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3236	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	1690	190.2	1	SNP	p	G120K	1	.	.	358	360	AAG	803	805	AAG	274;275;278	A;A;G	255;258;256	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3236	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	1690	190.2	1	SNP	p	N121D	0	.	.	361	363	AAC	806	808	AAC	281;278;279	A;A;C	264;260;259	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3236	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	1690	190.2	1	SNP	p	A121N	1	.	.	361	363	AAC	806	808	AAC	281;278;279	A;A;C	264;260;259	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12804	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4729	269.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1426	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	998	141.5	1	SNP	p	V57M	1	.	.	169	171	ATG	515	517	ATG	261;262;261	A;T;G	250;251;249	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
